On March 25, 2021, over 150 Scientific Research and Experimental Development (SR&ED) stakeholders participated in the 2021 SREDStakeholder webcast. A variety of topics were covered including SR&ED Medical issues, Technological Advancement (TA) in Patents, recent SR&ED court cases, SR&ED statistics and initiatives, and Tax Court Strategies in Covid. It was Read more…
Event Notification On March 25, 2021, SR&ED Stakeholder will be broadcasting their virtual webcast on SR&ED topics. Of particular interest to SR&ED claimants and preparers will be the sessions relating to new technological advancements and patents and SR&ED medical issues. The effects of COVID-19 on SR&ED claims and recent tax Read more…
Quality Control and Routine Testing are excluded from SR&ED claims because work of this nature does not result in technological advancements. The Eligibility of Work for SR&ED Investment Tax Credits Policy1, lists some exclusions for SR&ED claims. Quality control and routine testing are among those excluded items. This blog post Read more…
On May 14 over 180 SR&ED stakeholders participated in the 2020 SREDStakeholder webcast. A variety of topics were covered including SR&ED Medical issues, SR&ED statistics and success stories, impacts of COVID-19, CATA 2020 SR&ED initiative, recent legal rulings, and new tax court procedures. It was enlightening to hear varying perspectives Read more…
Event Notification On May 14, 2020, SR&ED Stakeholder will be broadcasting their virtual webcast on SR&ED topics. Of particular interest to SR&ED claimants and preparers will be the sessions relating to new CRA directives and the new CRA medical guidance paper. The effects of COVID-19 on SR&ED claims and recent Read more…